HomeNews & TopicsInfection ControlDefinitely not the flu: risk of death from COVID-19 3.5 times higher...

Definitely not the flu: risk of death from COVID-19 3.5 times higher than from flu

Published on

A new study published in CMAJ (Canadian Medical Association Journal) found that the risk of death from COVID-19 was 3.5 times higher than from influenza.

“We can now say definitively that COVID-19 is much more severe than seasonal influenza,” says Dr. Amol Verma, St. Michael’s Hospital, Unity Health Toronto, and the University of Toronto. “Patients admitted to hospital in Ontario with COVID-19 had a 3.5 times greater risk of death, 1.5 times greater use of the ICU, and 1.5 times longer hospital stays than patients admitted with influenza.”

These findings are similar to study results recently reported in France and the United States.

The study compared hospitalizations for influenza between November 1, 2019, and June 30, 2020, in 7 large hospitals in Toronto and Mississauga — areas with large populations and high levels of COVID-19. It included all patients admitted to medical services or the intensive care unit (ICU) for influenza or COVID-19. There were 783 hospitalizations for influenza in 763 unique patients compared with 1027 hospitalizations for COVID-19 in 972 unique patients (representing 23.5% of all hospitalizations for COVID-19 in Ontario during the study period).

Most patients hospitalized with COVID-19 had few other illnesses, and 21% were younger than 50 years of age. People younger than 50 also accounted for almost 1 in 4 (24%) admissions to the ICU.

“Many people believe that COVID-19 mainly affects older people,” says Dr. Verma. “It is true that COVID-19 affects older adults most severely. We found that among adults over 75 years who were hospitalized with COVID-19, nearly 40% died in hospital. But it can also cause very serious illness in younger adults. Adults under 50 accounted for 20% of all COVID-19 hospitalizations in the first wave of the pandemic. Nearly 1 in 3 adults younger than 50 hospitalized with COVID-19 required intensive care, and nearly 1 in 10 required an unplanned readmission to hospital after discharge.”

People hospitalized for COVID-19 had greater use of the ICU, were more likely to be put on a ventilator and had longer hospital stays than people with influenza.

“These differences may be magnified by low levels of immunity to the novel coronavirus compared with seasonal influenza, which results from past infections and vaccination,” says Dr. Verma. “Hopefully, the severity of COVID-19 will decrease over time as people are vaccinated against the virus and more effective treatments are identified. There is, unfortunately, also the possibility that variants of the virus could be even more severe.”

Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area” is published February 10, 2021.

Latest articles

SHN leads global advancement in endoscopy education

Health care is continually advancing, with new technologies and techniques being developed regularly. This...

St. Michael’s Hospital performs Toronto’s first robotic mitral valve repair

The surgery took place in St. Michael’s Hospital’s Schroeder BRAIN&HEART Centre, where a highly...

Research reveals why some cells are more susceptible to cancer

The ability of mutations to cause cancer depends on how fast they force cells...

Pharmacy is everywhere healthcare happens: a new era for pharmacy professionals

You can find pharmacy anywhere healthcare happens.  It’s easy to picture the pharmacist behind a...

More like this

Using AI to improve hand hygiene and patient safety

The Ottawa Hospital (TOH) is the first in Canada to implement the Artificially Intelligent...

New study examines social influence on vaccines

According to a recent study by John D. Dimoff, Ph.D., Assistant Professor of Graduate...

MIMOSA Pro device to treat diabetic foot ulcers, prevent limb amputation

St. Michael’s Hospital has received funding for a device that helps clinicians better treat...

V-161: A breakthrough in the fight against antibiotic-resistant VRE infections

V-161 targets a crucial enzyme in VRE, offering promise in combating antibiotic-resistant infections in...

Battling Bird Flu: Critical research to protect BC from Avian Influenza

Genome BC is funding a set of research projects to address the risk associated...

COVID-19, five years later

Five years after the start of the pandemic, experts from the MUHC, the Montreal...